Alpa Laboratories Limited — Board Meeting, 13-08-2025: Outcome of Board Meeting

Alpa Laboratories' board has approved the financial results for the quarter ended June 30, 2025. The company saw robust performance, reporting consolidated revenue from operations of ₹19.11 Cr. Total income reached ₹31.06 Cr, boosted by unrealized profits from investments. Consolidated net profit for the quarter stood at ₹11.77 Cr, leading to an Earnings Per Share (EPS) of ₹5.59. Furthermore, the Board gave its nod to the notice for the upcoming 37th Annual General Meeting. This update provides investors key insights into the company's recent financial health and upcoming corporate actions.